What neomycin products are being reviewed?
Because of the concerns raised by State departments of primary industry, the APVMA has decided to review oral, intramammary and injectable preparations of neomycin. No residue or animal safety concerns have been identified for topical formulations, neomycin used as an antibiotic preservation in small animal vaccines and semen extender powder preparations. Therefore, the review of neomycin will consider products used to treat food-producing animals including oral, intramammary and injectable preparations.
